资讯
The company had previously halted shipments to certain older patients following the deaths of two teenagers treated with the ...
A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...
The death of a 51-year-old man in the study follows two other deaths of Duchenne patients treated with Sarepta’s marketed ...
The anemia treatment missed its main goal in a myelofibrosis study. Meanwhile, Blenrep's return to the U.S. market may have ...
Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...
Overall venture funding, as well as “first financing” rounds, fell significantly in the second quarter, reversing 2025’s fast ...
The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...
Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy Spun out of the lab of former UCSF researcher Nicole Paulk, the biotech is targeting brain and eye tumors with a new ...
On a conference call, CEO Doug Ingram said the decision to cut 36% of the company's staff and halt several drug programs was ...
Novartis will spend $300 million to bolster its development and production capabilities for biologic medicines, which make up an increasing share of its drug pipeline. The Swiss drugmaker will invest ...
Quarterly pharmaceutical sales surpassed $15 billion for the first time as strong performance from J&J's cancer medicines ...
Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果